Viatris' global generics portfolio spans generic and complex generic medicines across major therapeutic areas, supplied in more than 165 countries.
Viatris produces generic and complex generic medicines that work in the same way and provide the same clinical benefits as their brand-name counterparts, across therapeutic areas spanning cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, infectious disease, oncology, respiratory and allergy, and women's healthcare. Its global portfolio is supported by more than 1,400 approved molecules and 80 billion-plus doses sold annually through a global manufacturing network inspected by health authorities worldwide.
The company backs its generics business with a deep development pipeline focused on complex products, including complex sterile products, topicals and transdermals, complex oral solid dosage forms, high-potency products, traditional generics, drug/device combinations, and complex injectables. Viatris develops new drugs through the 505(b)(2) regulatory pathway and New Chemical Entities, with a first-to-market emphasis, while investing in life-cycle management of key portfolio products.
| Attribute | Generics | Generics | |
|---|---|---|---|
| Provider |  |  | |
| Founded | 2020 | 1886 | |
| Sells To | Consumers, Enterprise | Healthcare Providers, Hospitals, Retail | |
| Pricing Model | Transactional | B2B, Product Sales | |
| Ownership | Public | Public |
Provider
Founded 2020
Sells To Consumers, Enterprise
Pricing Model Transactional
Ownership Public
Provider
Founded 1886
Sells To Healthcare Providers, Hospitals, Retail
Pricing Model B2B, Product Sales
Ownership Public
EMS's generic-medicines unit, Brazil's generics market leader since 2013, supplying pharmacies, distributors and public drug programs.
Medley manufactures generic medicines in Brazil, offering a portfolio across therapeutic categories at lower cost than branded equivalents.
EMS's generic-medicines unit, Brazil's generics market leader since 2013, supplying pharmacies, distributors and public drug programs.
Medley manufactures generic medicines in Brazil, offering a portfolio across therapeutic categories at lower cost than branded equivalents.